Sara Elizabeth Townsley

Array ( [id] => 8416718 [patent_doc_number] => 20120244218 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-09-27 [patent_title] => 'Calcium supplement' [patent_app_type] => utility [patent_app_number] => 13/065643 [patent_app_country] => US [patent_app_date] => 2011-03-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 4693 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13065643 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8792745 [patent_doc_number] => 20130109714 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-05-02 [patent_title] => 'NEURODEGENERATIVE DISEASE THERAPEUTIC AGENT' [patent_app_type] => utility [patent_app_number] => 13/637538 [patent_app_country] => US [patent_app_date] => 2011-03-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 7626 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13637538 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10620542 [patent_doc_number] => 09339466 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-05-17 [patent_title] => 'Polymorphic forms of ST-246 and methods of preparation' [patent_app_type] => utility [patent_app_number] => 13/069813 [patent_app_country] => US [patent_app_date] => 2011-03-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 18720 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 112 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13069813 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7697053 [patent_doc_number] => 20110229537 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-22 [patent_title] => 'ORAL SUPPLEMENT' [patent_app_type] => utility [patent_app_number] => 13/050523 [patent_app_country] => US [patent_app_date] => 2011-03-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4200 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0229/20110229537.pdf [firstpage_image] =>[orig_patent_app_number] => 13050523 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6102207 [patent_doc_number] => 20110165700 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-07-07 [patent_title] => 'CLASSES OF COMPOUNDS THAT INTERACT WITH INTEGRINS' [patent_app_type] => utility [patent_app_number] => 13/047601 [patent_app_country] => US [patent_app_date] => 2011-03-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5882 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0165/20110165700.pdf [firstpage_image] =>[orig_patent_app_number] => 13047601 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5972595 [patent_doc_number] => 20110152228 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-23 [patent_title] => 'SPRAYABLE PHARMACEUTICAL COMPOSITIONS COMPRISING A CORTICOID AND AN OILY PHASE' [patent_app_type] => utility [patent_app_number] => 13/038483 [patent_app_country] => US [patent_app_date] => 2011-03-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4925 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0152/20110152228.pdf [firstpage_image] =>[orig_patent_app_number] => 13038483 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8842007 [patent_doc_number] => 20130137635 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-05-30 [patent_title] => 'TRYPTOPHAN HYDROXYLASE INHIBITORS FOR THE TREATMENT OF METASTATIC BONE DISEASE' [patent_app_type] => utility [patent_app_number] => 13/577755 [patent_app_country] => US [patent_app_date] => 2011-02-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 52462 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13577755 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7657316 [patent_doc_number] => 20110306585 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-15 [patent_title] => 'Metal Complexes of N-Heterocyclic Carbenes' [patent_app_type] => utility [patent_app_number] => 13/021337 [patent_app_country] => US [patent_app_date] => 2011-02-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 16664 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0306/20110306585.pdf [firstpage_image] =>[orig_patent_app_number] => 13021337 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6055956 [patent_doc_number] => 20110112316 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-12 [patent_title] => 'TIGECYCLINE CRYSTALLINE FORMS AND PROCESSES FOR PREPARATION THEREOF' [patent_app_type] => utility [patent_app_number] => 13/006719 [patent_app_country] => US [patent_app_date] => 2011-01-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 4508 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0112/20110112316.pdf [firstpage_image] =>[orig_patent_app_number] => 13006719 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6121596 [patent_doc_number] => 20110077292 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-31 [patent_title] => 'FORSKOLIN CARBONATES AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 12/973860 [patent_app_country] => US [patent_app_date] => 2010-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4913 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0077/20110077292.pdf [firstpage_image] =>[orig_patent_app_number] => 12973860 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6213907 [patent_doc_number] => 20110136749 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-09 [patent_title] => 'COMPOUNDS USEFUL FOR TREATING NEURODEGENERATIVE DISORDERS' [patent_app_type] => utility [patent_app_number] => 12/957551 [patent_app_country] => US [patent_app_date] => 2010-12-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 19227 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0136/20110136749.pdf [firstpage_image] =>[orig_patent_app_number] => 12957551 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6213908 [patent_doc_number] => 20110136750 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-09 [patent_title] => 'COMPOUNDS USEFUL FOR TREATING NEURODEGENERATIVE DISORDERS' [patent_app_type] => utility [patent_app_number] => 12/957555 [patent_app_country] => US [patent_app_date] => 2010-12-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 19273 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0136/20110136750.pdf [firstpage_image] =>[orig_patent_app_number] => 12957555 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6033326 [patent_doc_number] => 20110082154 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-04-07 [patent_title] => 'Sigma ligands for neuronal regeneration and functional recovery' [patent_app_type] => utility [patent_app_number] => 12/926594 [patent_app_country] => US [patent_app_date] => 2010-11-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12488 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0082/20110082154.pdf [firstpage_image] =>[orig_patent_app_number] => 12926594 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10560634 [patent_doc_number] => 09284292 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-03-15 [patent_title] => 'Sialochimeric compounds' [patent_app_type] => utility [patent_app_number] => 13/512306 [patent_app_country] => US [patent_app_date] => 2010-11-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 16369 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13512306 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8476640 [patent_doc_number] => 20120276047 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-11-01 [patent_title] => 'FUSED TRICYCLIC COMPOUNDS AND DERIVATIVES THEREOF USEFUL FOR THE TREATMENT OF VIRAL DISEASES' [patent_app_type] => utility [patent_app_number] => 13/512073 [patent_app_country] => US [patent_app_date] => 2010-11-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 32959 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13512073 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6007955 [patent_doc_number] => 20110059986 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-10 [patent_title] => 'INTERMITTENT DOSING REGIMEN FOR OVERWEIGHT AND OBESE SUBJECTS' [patent_app_type] => utility [patent_app_number] => 12/947960 [patent_app_country] => US [patent_app_date] => 2010-11-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 5644 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0059/20110059986.pdf [firstpage_image] =>[orig_patent_app_number] => 12947960 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9582241 [patent_doc_number] => 08772244 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-07-08 [patent_title] => 'Tubulin inhibitors' [patent_app_type] => utility [patent_app_number] => 13/509060 [patent_app_country] => US [patent_app_date] => 2010-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 8 [patent_no_of_words] => 4289 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 5 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13509060 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5930630 [patent_doc_number] => 20110040266 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-02-17 [patent_title] => 'ANTI-INSOMNIA COMPOSITIONS AND METHODS' [patent_app_type] => utility [patent_app_number] => 12/912261 [patent_app_country] => US [patent_app_date] => 2010-10-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 4949 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0040/20110040266.pdf [firstpage_image] =>[orig_patent_app_number] => 12912261 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10147927 [patent_doc_number] => 09180192 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-11-10 [patent_title] => 'mGluR4 allosteric potentiators, compositions, and methods of treating neurological dysfunction' [patent_app_type] => utility [patent_app_number] => 13/503644 [patent_app_country] => US [patent_app_date] => 2010-10-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28172 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13503644 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8430928 [patent_doc_number] => 20120252803 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-10-04 [patent_title] => 'COMPOSITION AND METHOD FOR CONTROLLING ARTHROPOD PESTS' [patent_app_type] => utility [patent_app_number] => 13/502815 [patent_app_country] => US [patent_app_date] => 2010-10-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 74568 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13502815 [rel_patent_id] =>[rel_patent_doc_number] =>)